MG
VRTX icon

McHugh Group’s Vertex Pharmaceuticals VRTX Stock Holding History

McHugh Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Hold
500
– – 0.13% 78
2026
Q1 		$223K Hold
500
– – 0.13% 75
2025
Q4 		$227K Buy
+500
New +$216K 0.13% 74
2025
Q3 		– Sell
-500
Closed -$223K – 81
2025
Q2 		$223K Hold
500
– – 0.15% 62
2025
Q1 		$242K Hold
500
– – 0.18% 54
2024
Q4 		$201K Buy
+500
New +$232K 0.15% 67

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

McHugh Group's VRTX Position: Q2 2026 in Review

McHugh Group held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 500 shares worth $248K. The position accounts for 0.13% of the portfolio, ranked #78.

McHugh Group first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • McHugh Group held 500 shares of Vertex Pharmaceuticals worth $248K as of Q2 2026.
  • McHugh Group left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.13% of McHugh Group's portfolio in Q2 2026, its #78 holding.
  • McHugh Group first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on McHugh Group's 13F filing for Q2 2026, filed 16 Jul 2026.